Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -6.72% vs 28.69% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -98.08% vs 133.77% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -30.28% vs 2,394.74% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 3.03% vs -35.29% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Nanjing Vazyme Biotech Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 12.57% vs -26.98% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -6.72% vs 28.69% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -89.47% vs 105.19% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -98.08% vs 133.77% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 49.75% vs 286.24% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -30.28% vs 2,394.74% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -2.86% vs 84.21% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 3.03% vs -35.29% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






